PMD Psychemedics
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
Company profile
Ticker
PMD
Exchange
Website
CEO
Raymond C. Kubacki
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
Corporate docs
IRS number
581701987
PMD stock data
()
News
Cannabis Stock Gainers And Losers From June 11, 2021
11 Jun 21
Stocks That Hit 52-Week Highs On Friday
11 Jun 21
Cannabis Stock Gainers And Losers From June 8, 2021
8 Jun 21
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)
27 May 21
Psychemedics Q1 EPS $0.01 Up From $(0.03) YoY, Sales $5.70M Down From $7.54M YoY
10 May 21
Press releases
Calendar
13 May 21
13 Jun 21
31 Dec 21
Financial summary
Quarter (USD) |
Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Financial data from company earnings reports.
| Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.19M | 2.19M | 2.19M | 2.19M | 2.19M | 2.19M |
| Cash burn (monthly) | 214.33K | 53.58K | (positive/no burn) | 481.17K | 137.67K | 340.25K |
| Cash used (since last report) | 526.13K | 131.53K | n/a | 1.18M | 337.93K | 835.22K |
| Cash remaining | 1.66M | 2.06M | n/a | 1.01M | 1.85M | 1.35M |
| Runway (months of cash) | 7.8 | 38.4 | n/a | 2.1 | 13.5 | 4.0 |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 13 May 21 | Andrew Limbek | Common Stock, $.005 Par Value | Grant | Aquire A | No | No | 0 | 6,000 | 0 | 7,500 |
| 13 May 21 | Charles M Doucot | Common Stock, $.005 Par Value | Grant | Aquire A | No | No | 0 | 12,000 | 0 | 30,500 |
| 13 May 21 | Raymond C Kubacki JR | Common Stock, $.005 Par Value | Grant | Aquire A | No | No | 0 | 23,000 | 0 | 237,374 |
| 13 May 21 | Fred J Weinert | Common Stock, $.005 Par Value | Grant | Aquire A | No | No | 0 | 11,000 | 0 | 58,583 |
| 13 May 21 | Walter S Tomenson | Common Stock, $.005 Par Value | Grant | Aquire A | No | No | 0 | 11,000 | 0 | 62,399 |
Institutional ownership Q4 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
36.8% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 32 |
| Opened positions | 3 |
| Closed positions | 5 |
| Increased positions | 3 |
| Reduced positions | 15 |
13F shares |
Current |
|---|---|
| Total value | 10.38M |
| Total shares | 2.04M |
| Total puts | 0 |
| Total calls | 0 |
| Total put/call ratio | – |
Largest owners |
Shares | Value |
|---|---|---|
| Renaissance Technologies | 454.64K | $2.31M |
| Crawford Investment Counsel | 299.56K | $1.53M |
| Vanguard | 253.52K | $1.29M |
| Tieton Capital Management | 164.46K | $837K |
| Invenomic Capital Management | 133.61K | $680K |
| Dimensional Fund Advisors | 115.46K | $588K |
| BLK Blackrock | 101.33K | $516K |
| Ancora Advisors | 85.45K | $435K |
| RBF Capital | 78.5K | $400K |
| 22NW | 75.53K | $384K |
Financial report summary
?Competition
Quest DiagnosticsContent analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
began, CAA, case, clarifying, COVID, creation, decision, Depending, employee, entitled, established, experience, FFCRA, flow, GAAP, hand, job, modified, Notwithstanding, November, pay, permitted, predict, prioritize, prospective, recommendation, recovery, recurring, removing, request, retention, retrospective, sample, slower, unable
Removed:
addition, aggregate, antidilutive, approximate, broad, carrying, chain, cleaning, closed, comply, component, continuing, defer, deferral, determine, disrupted, distribution, documented, eligibility, enhanced, estimated, event, exposure, fall, FICA, Finance, forgiven, historically, increased, ineligible, inherent, initial, lessen, license, local, longer, mitigated, month, notice, NPV, obtained, operational, political, portion, potentially, primary, prior, protective, receipt, received, reduce, rent, repay, review, satisfied, short, situation, sum, supply, terminated, transpire, unemployment, written
Financial reports
10-Q
2021 Q1
Quarterly report
13 May 21
10-K/A
2020 FY
Annual report (amended)
9 Apr 21
10-K
2020 FY
Annual report
26 Mar 21
10-Q
2020 Q3
Quarterly report
10 Nov 20
10-Q
2020 Q2
Quarterly report
13 Aug 20
10-Q
2020 Q1
Quarterly report
15 May 20
10-K/A
2019 FY
Annual report (amended)
27 Feb 20
10-K
2019 FY
Annual report
25 Feb 20
10-Q
2019 Q3
Quarterly report
24 Oct 19
10-Q
2019 Q2
Quarterly report
24 Jul 19
Current reports
8-K
Departure of Directors or Certain Officers
17 May 21
8-K
Psychemedics Corporation Reports First Quarter 2021 Financial Results
10 May 21
8-K
Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
23 Mar 21
8-K
Robyn C. Davis Joins Psychemedics Board of Directors
17 Mar 21
8-K
Departure of Directors or Certain Officers
27 Jan 21
8-K
Departure of Directors or Certain Officers
16 Nov 20
8-K
Psychemedics Announces Third Quarter Results
9 Nov 20
8-K
Entry into a Material Definitive Agreement
8 Nov 20
8-K
Departure of Directors or Certain Officers
10 Sep 20
8-K
Psychemedics Announces Second Quarter Results
12 Aug 20
Registration and prospectus
S-8
Registration of securities for employees
25 May 21
S-8
Registration of securities for employees
13 Aug 19
S-8
Registration of securities for employees
31 May 16
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Mar 16
S-8
Registration of securities for employees
25 May 11
POS AM
Prospectus update (post-effective amendment)
3 Feb 11
POS AM
Prospectus update (post-effective amendment)
3 Feb 11
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jan 11
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Jan 11
Proxies
DEF 14A
Definitive proxy
6 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
DEFA14A
Additional proxy soliciting materials
28 Apr 20
DEF 14A
Definitive proxy
27 Mar 20
DEFA14A
Additional proxy soliciting materials
8 Apr 19
DEFA14A
Additional proxy soliciting materials
25 Mar 19
DEF 14A
Definitive proxy
19 Mar 19
DEF 14A
Definitive proxy
20 Mar 18
DEF 14A
Definitive proxy
29 Mar 17
DEF 14A
Definitive proxy
28 Mar 16
Ownership
4
PSYCHEMEDICS / MICHAEL I SCHAFFER ownership change
14 May 21
4
PSYCHEMEDICS / Robyn C Davis ownership change
14 May 21
4
PSYCHEMEDICS / FRED J WEINERT ownership change
14 May 21
4
PSYCHEMEDICS / WALTER S TOMENSON ownership change
14 May 21
4
PSYCHEMEDICS / HARRY F CONNICK SR ownership change
14 May 21
4
PSYCHEMEDICS / RAYMOND C KUBACKI JR ownership change
14 May 21
4
PSYCHEMEDICS / Andrew Limbek ownership change
14 May 21
4
PSYCHEMEDICS / Charles M Doucot ownership change
14 May 21
4
PSYCHEMEDICS / Robyn C Davis ownership change
18 Mar 21
3
PSYCHEMEDICS / Robyn C Davis ownership change
18 Mar 21
Patents
APP
Utility
Homogeneous Enzyme Immunoassay for Keratinized Structures
18 Feb 21
This disclosure relates to methods and kits for determining the presence and/or amount of one or more analytes in a keratinized structure (e.g., hair) sample.
GRANT
Utility
Solid phase multi-analyte assay
20 Jan 20
Compositions and methods for detecting the presence and/or amount of one or more analytes, including analytes such as drugs of abuse, are provided.
Reddit threads
Daily Discussion Thread - May 11th, 2021
11 May 21
Daily Discussion Thread - May 10th, 2021
10 May 21
It's almost as if Seeking Alpha has a vested interest in PTON......
6 Apr 21
Image Protect Inc. ($IMTL) announces change to business model and new acquisition
25 Mar 21
NFT stocks volatility
23 Mar 21
Daily Discussion Thread - March 23rd, 2021
23 Mar 21
$CLIS Acquiring Rebel Blockchain
22 Mar 21
Daily Discussion Thread - March 22nd, 2021
22 Mar 21
Daily Discussion Thread - March 16th, 2021
16 Mar 21
Daily Discussion Thread - March 15th, 2021
15 Mar 21